ResearcherSuzhou Transcenta Therapeutics Co.No recent work listed

Charlie Qi

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 7 November 2026

Known by name at one institution; no external author ID yet. Sources: ClinicalTrials.gov.

Their work

Papers: 0
Trials: 1
Grants: 0
Labs led: 0
Collaborators: 0

Papers, trials and grants by year

2020: 1 trial

Trials 1

A Trial to Evaluate Safety and Tolerability of TST001 in Advanced or Metastatic Solid Tumors Study director NCT04396821 ↗

Closest collaborators

No collaborators recorded.

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.